Salarius Pharmaceuticals Announces Board of Director Nominations in Advance of 2020 Annual Meeting
HOUSTON, April 29, 2020 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biotechnology company targeting cancers caused by […]